| Date Filed | Type | Description |
| 05/02/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/17/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 02/24/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/14/2023 |
SC 13G/A
| SB Global Advisers Ltd reports a 8.6% stake in Pear Therapeutics, Inc. |
| 02/09/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 01/24/2023 |
4
| O'Brien Ronan (GC, CCO & Secretary) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Sold 12,162 shares
@ $1.13, valued at
$13.7k
|
|
| 01/24/2023 |
4
| Snow Ellen (Chief Accounting Officer) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Sold 8,027 shares
@ $1.13, valued at
$9.1k
|
|
| 01/24/2023 |
4
| Strandberg Julia (Chief Commercial Officer) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Sold 12,688 shares
@ $1.13, valued at
$14.3k
|
|
| 01/24/2023 |
4
| Brenner Erin K. (Chief Product Dev. Officer) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Sold 8,690 shares
@ $1.13, valued at
$9.8k
|
|
| 01/24/2023 |
4
| GUIFFRE CHRISTOPHERD T (CFO, COO, Treas., & Asst. Sec.) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Sold 19,540 shares
@ $1.13, valued at
$22.1k
|
|
| 01/24/2023 |
4
| Jeffery Katherine (Chief People Officer) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Sold 7,096 shares
@ $1.13, valued at
$8k
|
|
| 01/24/2023 |
4
| Maricich Yuri (Chief Medical Officer) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Sold 12,162 shares
@ $1.13, valued at
$13.7k
|
|
| 01/24/2023 |
4
| McCann Corey (President and CEO) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Sold 34,731 shares
@ $1.13, valued at
$39.2k
|
|
| 01/18/2023 |
4
| Brenner Erin K. (Chief Product Dev. Officer) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Exercised 22,000 restricted stock units
@ $0 |
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/10/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 01/04/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 01/04/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/03/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/03/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 01/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 01/03/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 12/13/2022 |
4
| LJ10 LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Disposed of 430,000 shares
@ $0 |
|
| 12/09/2022 |
4
| Brenner Erin K. (Chief Product Dev. Officer) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Exercised 15,000 options to buy
@ $1, valued at
$15k
|
|
| 11/15/2022 |
4
| 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Sold 28,205 shares
@ $3.19, valued at
$90k
Sold 1,175 shares
@ $3.19, valued at
$3.7k
Sold 11,643 shares
@ $2.79, valued at
$32.5k
Sold 485 shares
@ $2.79, valued at
$1.4k
Sold 61,222 shares
@ $2.52, valued at
$154.3k
Sold 2,551 shares
@ $2.52, valued at
$6.4k
|
|
| 11/14/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
|